CR2408

pan-histone deacetylase inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Multiple Myeloma 03/01/2012 - "The pan-histone deacetylase inhibitor CR2408 disrupts cell cycle progression, diminishes proliferation and causes apoptosis in multiple myeloma cells." 03/01/2012 - "In view of the fact that histone deacetylases (HDACs) are promising targets for myeloma therapy, we investigated the effects of the HDAC inhibitor CR2408 on multiple myeloma (MM) cells in vitro. "

1.	Histone Deacetylase Inhibitors
2.	Histone Deacetylases (Histone Deacetylase)

1.	Therapeutics